Disparities in availability of new cancer drugs worldwide: 1990-2022.

ABSTRACT:

Introduction

Despite progress in the development of new cancer drugs, concerns about equity of access remain. This study aimed to examine the availability and timeliness of availability of new cancer drugs around the globe over the past three decades and their associations with country characteristics.

Methods

From a pharmaceutical intelligence database we identified new cancer drugs launched between 1990 and 2022. We calculated the number of new drugs launched in each country and the delay in launches. Using a multivariable linear regression and a Cox regression model with shared frailty, we examined the associations of the country's Gross National Income (GNI) per capita, cancer incidence, number of physicians per population, and Gini index with the number of new cancer dr

SUBMITTER: Li M 

PROVIDER: S-EPMC11481112 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature